A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses
Status:
Completed
Trial end date:
2021-03-03
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetics (PK), tolerability, and safety of brexpiprazole QW
formulation administered as single and multiple doses in patients with schizophrenia.